Philips' earnings call presented a balanced view, with strong order intake growth and margin expansion offset by declines in certain segments and challenges in China. The company is optimistic about the second half of 2025, with improved outlooks for free cash flow and EBITA margin, despite the ongoing tariff impacts.

Company Guidance -

Q3 2025

During Philips' second quarter and semiannual 2025 results conference call, the company reported significant metrics and provided guidance for the remainder of the year. Order intake grew by 6% compared to the previous year, driven by strong performance in North America and growth geographies. Comparable sales increased by 1%, with Personal Health showing strength, while Diagnosis & Treatment (D&T) and Connected Care experienced varied results. The margin expanded by 130 basis points to 12.4%, reflecting the impact of innovations and productivity measures. Philips maintained its full-year comparable sales growth outlook at 1% to 3% and increased its 2025 adjusted EBITA margin range to 11.3% to 11.8% due to recent tariff developments. Additionally, the company expects full-year free cash flow to be between EUR 0.2 billion and EUR 0.4 billion, dependent on the current tariff levels holding. The company highlighted strong order intake in Diagnosis & Treatment, particularly in Image-Guided Therapy and Precision Diagnosis, and resilient demand in Connected Care. Personal Health achieved growth in all segments, supported by partnerships with major retailers. Philips emphasized ongoing efforts in quality management and supply chain reliability, achieving a service level of 86% in Q2. Looking ahead, the company plans to host a Capital Markets Day in February 2026, focusing on accelerating profitable growth and strategy beyond 2025.

Order Intake Growth

Order intake grew by 6% in Q2, building on a 9% growth from the previous year, with strong performance across North America and growth geographies.

Margin Expansion

Comparable sales increased by 1%, and margin expanded by 130 basis points to 12.4%, driven by innovation and productivity measures.

Innovations in Diagnosis & Treatment

Strong demand for recently launched innovations in Image-Guided Therapy and Precision Diagnosis, with double-digit order growth in these areas.

Improvement in Personal Health

All three businesses within the Personal Health segment grew, with strong traction from new innovations and partnerships with high-performing retailers.

Supply Chain and Quality Improvements

Service levels reached an all-time high of 86%, and product updates and field actions were reduced by approximately 20%.

Positive Free Cash Flow Projections

Full-year free cash flow is expected to be between EUR 0.2 billion and EUR 0.4 billion, an increase from the previous outlook.

Koninklijke Philips (PHG) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

PHG Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2025 (Q3)	0.37 / -	0.338	―	―	―
Jul 29, 2025	2025 (Q2)	0.32 / 0.41	0.324	28.09% (+0.09)
May 06, 2025	2025 (Q1)	0.20 / 0.28	0.269	5.58% (+0.01)
Feb 19, 2025	2024 (Q4)	0.57 / 0.53	0.426	24.88% (+0.11)
Oct 28, 2024	2024 (Q3)	0.44 / 0.34	0.338	0.00% (0.00)
Jul 29, 2024	2024 (Q2)	0.36 / 0.32	0.288	12.50% (+0.04)
Apr 29, 2024	2024 (Q1)	0.29 / 0.27	0.225	19.56% (+0.04)
Jan 29, 2024	2023 (Q4)	0.56 / 0.43	0.413	3.15% (+0.01)
Oct 23, 2023	2023 (Q3)	0.30 / 0.34	0.229	47.60% (+0.11)
Jul 24, 2023	2023 (Q2)	0.28 / 0.29	0.132	118.18% (+0.16)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

PHG Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 29, 2025	$25.66	$28.02	+9.20%
May 06, 2025	$24.87	$23.36	-6.07%
Feb 19, 2025	$27.46	$24.30	-11.51%
Oct 28, 2024	$30.72	$25.82	-15.95%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.